Anaplastic large cell lymphoma (ALCL), ALK-positive, is a type of non-Hodgkin lymphoma characterized by the proliferation of large atypical lymphoid cells. This condition primarily affects lymph nodes in the head, face, and neck region. Accurate coding with ICD-10 Code C84.61 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this malignancy.
ICD-10 Code C84.61 represents anaplastic large cell lymphoma that is anaplastic lymphoma kinase (ALK) positive, specifically affecting the lymph nodes of the head, face, and neck. This code is used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, which is critical for treatment planning and reimbursement processes.
Anaplastic large cell lymphoma (ALCL), ALK-positive, is a rare and aggressive form of non-Hodgkin lymphoma that arises from T-cells. It is characterized by the presence of the ALK gene rearrangement, which plays a significant role in the pathogenesis of the disease. Prompt diagnosis and treatment are crucial due to its aggressive nature and potential for systemic involvement.
ICD-10 Code C84.61 is utilized in SOAP notes to document the diagnosis of anaplastic large cell lymphoma, ALK-positive. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.61 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of anaplastic large cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of anaplastic large cell lymphoma, ALK-positive, often requires urgent intervention due to its aggressive nature. Treatment typically involves chemotherapy and may include targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.61 is crucial for billing purposes in hospital, emergency room, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77021 | Computed tomography, lymph nodes, neck. |
Common Questions About Using ICD-10 Code C84.61 for Anaplstc lg cell lymph, ALK-pos, nodes of head, face, and nk
What are the common symptoms of ALK-positive anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience systemic symptoms due to the aggressive nature of the disease.
How is anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of ALK-positive cells.
What treatment options are available for this condition?
Treatment usually includes chemotherapy regimens, targeted therapy for ALK-positive cases, and supportive care to manage symptoms and side effects.
Is anaplastic large cell lymphoma curable?
While anaplastic large cell lymphoma can be aggressive, many patients respond well to treatment, and long-term remission is possible, especially with early intervention.
Clinical Notes
SOAP notes
DAP notes
AI medical notes